Evidence map›Paper›PMID 36208067›Full record

Observational studyJournal of diabetes investigation2023

Change in fatty acid composition of plasma triglyceride caused by a 2 week comprehensive risk management for diabetes: A prospective observational study of type 2 diabetes patients with supercritical fluid chromatography/mass spectrometry-based semi-target lipidomic analysis.

Naohiro Taya, Naoto Katakami, Kazuo Omori, Shigero Hosoe, Hirotaka Watanabe, Mitsuyoshi Takahara, Kazuyuki Miyashita, Hitoshi Nishizawa, Yutaka Konya, Sachiko Obara and 6 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of diabetes investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Naohiro TayaDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Naoto KatakamiDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID https://orcid.org/0000-0001-9020-8320
Kazuo OmoriDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Shigero HosoeDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Hirotaka WatanabeDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Mitsuyoshi TakaharaDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID https://orcid.org/0000-0001-5105-041X
Kazuyuki MiyashitaDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID https://orcid.org/0000-0001-7499-9919
Hitoshi NishizawaDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID https://orcid.org/0000-0002-7845-9693
Yutaka KonyaDivision of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Sachiko ObaraDivision of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Ayako HidakaDivision of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Motonao NakaoDivision of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Masatomo TakahashiDivision of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Yoshihiro IzumiDivision of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Iichiro ShimomuraDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Takeshi BambaDivision of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

Funding

AMEDJapan Agency for Medical Research and Development JP19gm0710005Japan Agency for Medical Research and Development JP21gm0910013Japan Agency for Medical Research and Development JP21gm101001Japan Diabetes FoundationManpei Suzuki Diabetes Foundation
6 · The paper itself

Abstract

AIMS/

introductionHypertriglyceridemia is common in patients with diabetes. Although the fatty acid (FA) composition of triglycerides (TGs) is suggested to be related to the pathology of diabetes and its complications, changes in the fatty acid composition caused by diabetes treatment remain unclear. This study aimed to identify short-term changes in the fatty acid composition of plasma triglycerides after diabetes treatment. MATERIALS AND

methodsThis study was a sub-analysis of a prospective observational study of patients with type 2 diabetes aged between 20 and 75 years who were hospitalized to improve glycemic control (n = 31). A lipidomic analysis of plasma samples on the 2nd and 16th hospital days was conducted by supercritical fluid chromatography coupled with mass spectrometry.

resultsIn total, 104 types of triglycerides with different compositions were identified. Most of them tended to decrease after treatment. In particular, triglycerides with a lower carbon number and fewer double bonds showed a relatively larger reduction. The inclusion of FA 14:0 (myristic acid), as a constituent of triglyceride, was significantly associated with a more than 50%, and statistically significant, reduction (odds ratio 39.0; P < 0.001). The total amount of FA 14:0 as a constituent of triglycerides also decreased significantly, and its rate of decrease was the greatest of all the fatty acid constituents.

conclusionsA 2 week comprehensive risk management for diabetes resulted in decreased levels of plasma triglycerides and a change in the fatty acid composition of triglycerides, characterized by a relatively large reduction in FA 14:0 as a constituent of triglycerides.

Indexed as

Chromatography, Supercritical FluidDiabetes Mellitus, Type 2AdultAgedFatty AcidsHumansLipidomicsMass SpectrometryMiddle AgedRisk ManagementTriglyceridesYoung AdultFatty AcidsTriglyceridesDiabetes treatmentLipidomicsMyristic acids

Identifiers

PMID36208067
PMCPMC9807157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.